BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 8332084)

  • 1. Induction of micronucleated erythrocytes by recombinant human erythropoietin.
    Yajima N; Kurata Y; Sawai T; Takeshita Y
    Mutagenesis; 1993 May; 8(3):221-9. PubMed ID: 8332084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity studies on HM10760A, recombinant human erythropoietin conjugated to globin fragment.
    Kwon SC; Lee GS; Han JY; Lee M; Lee YM; Koh WS; Kim JY
    Drug Chem Toxicol; 2010 Apr; 33(2):152-9. PubMed ID: 19761439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity of genetic recombinant human erythropoietin in a novel test system.
    Yajima N; Kurata Y; Imai E; Sawai T; Takeshita Y
    Mutagenesis; 1993 May; 8(3):231-6. PubMed ID: 8332085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxicity assessment of pirmenol, a new antiarrhythmic drug.
    Ciaravino V; Kropko ML; Krishna G; Monteith DK; Theiss JC
    Mutat Res; 1992; 280(3):205-14. PubMed ID: 1381484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutagenicity studies of lactitol (NS-4)].
    Iwakura K; Tamura H; Watanabe M; Sumi N
    J Toxicol Sci; 1994 Nov; 19 Suppl 3():487-97. PubMed ID: 7837301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies in induction of micronuclei by three genetically recombinant and urinary human erythropoietins.
    Yajima N; Kurata Y; Sawai T; Takeshita Y
    Mutagenesis; 1993 May; 8(3):237-41. PubMed ID: 8332086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity studies on licorice flavonoid oil (LFO).
    Nakagawa K; Hidaka T; Kitano M; Asakura M; Kamigaito T; Noguchi T; Hosoe K
    Food Chem Toxicol; 2008 Jul; 46(7):2525-32. PubMed ID: 18502556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity evaluation of Hwanglyeonhaedok-tang, an herbal formula.
    Jin SE; Lee MY; Seo CS; Ha H; Kim JY; Shin HK
    J Ethnopharmacol; 2017 Apr; 202():122-126. PubMed ID: 27916588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicology and carcinogenesis studies of pyrogallol (CAS No. 87-66-1) in F344/N rats and B6C3F1/N mice (dermal studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Feb; (574):1-167. PubMed ID: 23518671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutagenicity studies of prednisolone farnesylate (PNF)].
    Otsuka M; Ajimi S; Kajiwara Y; Ogura S; Kakimoto K; Inai T; Tanaka H; Ohuchida A
    J Toxicol Sci; 1992 Nov; 17 Suppl 3():269-81. PubMed ID: 1293327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutagenicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
    Tamura H; Yamashita Y; Kitayama E; Iwakura K; Watanabe M; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():263-74. PubMed ID: 9170614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity assessment of two hypergolic energetic propellant compounds.
    Reddy G; Song J; Mecchi MS; Johnson MS
    Mutat Res; 2010 Jul; 700(1-2):26-31. PubMed ID: 20417306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity studies with palm fruit carotene.
    Masuda M; Haresaku M; Takei T; Nakamura T
    J Toxicol Sci; 1995 Nov; 20(5):619-27. PubMed ID: 8720168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity tests of polyoxyethylene hydrogenated castor oil 60 (HCO-60).
    Hirai O; Miyamae Y; Zaizen K; Miyamoto A; Takashima M; Hattori Y; Ohara K; Mine Y
    J Toxicol Sci; 1994 May; 19(2):89-96. PubMed ID: 8072043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genotoxicity studies of cefmatilen hydrochloride hydrate (S-1090)].
    Kondo K; Takase S; Nishimoto Y; Miyajima H; Shiratori O; Miyake Y
    J Toxicol Sci; 2001 May; 26 Suppl 1():243-54. PubMed ID: 11400316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of genetic toxicity of 6-diazo-5-oxo-l-norleucine (DON).
    Kulkarni RM; Dakoulas EW; Miller KE; Terse PS
    Toxicol Mech Methods; 2017 Sep; 27(7):518-527. PubMed ID: 28552037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity of recombinant antihemophilic factor (GC-gamma AHF).
    Shin M; Kim B; Mar W; Fang M; Son J; Kim M; Kwak H; Bae M; Byun T; Park S; Chun B; Byun J; An G; Lee B; Cho M
    Arzneimittelforschung; 2000 Mar; 50(3):316-21. PubMed ID: 10758786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutagenicity studies of (+/-)-4-diethylamino-1,1,-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence].
    Otsuka M; Kajiwara Y; Ajimi S; Shimazaki H; Kikuno T; Ogura S; Inai T; Kakimoto K; Tamura H; Watanabe M; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():251-61. PubMed ID: 9170613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutagenicity studies of prulifloxacin (NM441) and the active metabolite (NM394)].
    Iwakura K; Tamura H; Yamashita Y; Watanabe M; Sumi N; Shindo Y; Ando M; Kojima M
    J Toxicol Sci; 1996 Jun; 21 Suppl 1():241-57. PubMed ID: 8709165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.